English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2077]
News [6447]
Articles [133]
Editorials [5]
Conferences [170]
elearning [10]
Newly discovered DNA repair mechanisms point to potential therapy targets for cancer and neurodegenerative diseases
Newly discovered DNA repair mechanisms point to potential therapy targets for cancer and neurodegenerative diseases
Young-onset cancers in Australia rise, and experts don't know why
Young-onset cancers in Australia rise, and experts don't know why
Scientists demonstrate utility of bilateral tumour model for evaluating anti-cancer T-cell responses
Scientists demonstrate utility of bilateral tumour model for evaluating anti-cancer T-cell responses
Early prostate cancers can harbour aggressive tumour cells
Early prostate cancers can harbour aggressive tumour cells
Matched targeted treatment based on ESCAT actionable genomic alterations associates with improved prognosis of cholangiocarcinoma patients
Matched targeted treatment based on ESCAT actionable genomic alterations associates with improved prognosis of...
Metabolic vulnerabilities could be new targets for metastatic breast cancer
Metabolic vulnerabilities could be new targets for metastatic breast cancer
Mouse study identifies bacterial protein associated with colorectal cancers
Mouse study identifies bacterial protein associated with colorectal cancers
Identification of a novel therapeutic target in multiple myeloma
Identification of a novel therapeutic target in multiple myeloma
Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen
Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen
Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma
Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma
<1...112113114115116...645>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top